Townsend Richard Nolan 4
4 · Lexeo Therapeutics, Inc. · Filed Aug 20, 2025
Insider Transaction Report
Form 4
Townsend Richard Nolan
DirectorChief Executive Officer
Transactions
- Sale
Common Stock
2025-08-18$4.67/sh−2,735$12,767→ 220,058 total
Footnotes (2)
- [F1]Represents a sale to cover tax obligations on the release of restricted stock units ("RSUs").
- [F2]Includes 131,092 RSUs.